Equities

Jin Medical International Ltd

ZJYL:NAQ

Jin Medical International Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.44
  • Today's Change-0.17 / -10.56%
  • Shares traded528.79k
  • 1 Year change+215.44%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.

  • Revenue in USD (TTM)20.13m
  • Net income in USD2.91m
  • Incorporated2020
  • Employees245.00
  • Location
    Jin Medical International LtdNo. 33 Lingxiang Road, Wujin DistrictCHANGZHOU 213149ChinaCHN
  • Phone+86 51 989607972
  • Websitehttp://ir.zhjmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nevro Corp419.15m-69.31m198.35m1.22k--0.7279--0.4732-1.89-1.8911.407.310.72441.106.01344,976.10-11.98-13.64-14.11-16.6868.0268.54-16.54-20.673.76-9.480.4482--4.631.88-3,172.74--0.9012--
Accuray Inc444.20m-20.08m199.12m987.00--4.40--0.4483-0.2032-0.20324.480.45030.93532.015.25450,054.70-4.23-1.37-7.35-2.3331.0936.43-4.52-1.550.8655-0.09360.7901---0.23551.29-67.51---3.54--
Neuropace Inc71.82m-29.90m212.55m171.00--21.46--2.96-1.09-1.092.610.33920.73051.746.49419,994.20-30.41---34.66--74.15---41.63--5.47-4.370.8565--43.72--30.00------
Trubridge Inc336.56m-52.28m213.61m3.22k--1.18--0.6347-3.68-3.6823.6412.120.7947196.765.88104,553.30-12.661.25-14.341.4148.7050.40-15.931.561.760.61150.498545.063.913.89-387.73--88.71--
Electromed Inc54.72m5.15m225.59m174.0046.355.2037.654.120.57910.57916.175.161.123.272.25314,459.8010.518.6412.5110.0976.2676.269.418.065.27--0.000.0013.8311.8262.6721.06-22.23--
Sight Sciences Inc79.40m-52.32m230.91m214.00--2.26--2.91-1.06-1.061.612.030.4741.534.18371,004.70-31.24-38.78-34.01-42.2085.8080.74-65.90-105.1410.50-26.500.2494--13.6360.8435.59--6.77--
Orchestra Biomed Holdings Inc2.08m-55.58m231.86m56.00--4.98--111.53-1.57-1.570.05861.230.0211.3416.5737,125.00-56.06---64.66--92.02---2,673.26--4.58--0.00---21.88---37.91------
Utah Medical Products, Inc.46.58m15.63m238.25m169.0015.821.9312.055.124.334.3312.9235.450.35761.9912.81275,609.5012.0012.6912.4313.1958.9961.5733.5630.5123.68--0.0037.05-3.933.640.98341.659.711.86
Atlantic International Corp205.26m-62.29m249.73m7.00--9.54--1.22-8.72-8.7214.590.52222.91--7.0329,322,780.00-88.44-71.97-174.30-106.0910.7061.01-30.35-1,471.82---1.330.7735---100.00---37.43------
Anika Therapeutics Inc164.17m-97.52m250.00m357.00--1.39--1.52-6.64-6.6411.1412.240.58681.475.21459,854.30-34.86-5.41-38.55-5.8762.7060.70-59.40-12.603.78--0.00--6.679.56-456.34--3.11--
Jin Medical International Ltd20.13m2.91m252.04m245.0086.379.6082.7012.520.01860.01860.12920.16760.55762.384.2282,143.597.8012.8111.2720.9234.7333.5813.9914.602.27--0.27020.003.29-1.076.34-4.80-9.50--
Inogen Inc326.65m-92.44m261.38m834.00--1.39--0.8002-3.97-3.9713.977.910.95626.857.49391,670.30-27.06-8.23-33.51-9.5342.5644.54-28.30-10.312.37--0.00---16.32-2.49-22.30--26.34--
Zynex Inc193.67m4.82m296.16m1.10k62.808.4131.671.530.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Pulmonx Corp79.30m-57.11m298.13m279.00--3.17--3.76-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
AngioDynamics, Inc.292.73m-243.03m302.32m748.00--1.55--1.03-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
LifeMD Inc178.28m-26.60m305.79m207.00------1.72-0.7004-0.70044.70-0.1013.596.8638.19861,255.40-44.31-153.05-333.96-526.9188.9283.66-12.34-45.440.8327-8.191.13--28.1578.9051.27--143.64--
Data as of Nov 12 2024. Currency figures normalised to Jin Medical International Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.78%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 2024593.07k0.38%
Vanguard Fiduciary Trust Co.as of 30 Jun 2024147.25k0.09%
Invesco Capital Management LLCas of 30 Jun 2024128.43k0.08%
Winton Capital Management Ltd.as of 30 Jun 2024122.39k0.08%
Geode Capital Management LLCas of 30 Jun 2024106.54k0.07%
UBS Securities LLCas of 30 Jun 202473.12k0.05%
Squarepoint OPS LLCas of 30 Jun 202433.24k0.02%
Schonfeld Strategic Advisors LLCas of 30 Jun 202412.80k0.01%
Morgan Stanley & Co. LLCas of 30 Jun 20242.94k0.00%
Wyoming State Treasurer (Investment Management)as of 30 Jun 2024323.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.